行情

CPHI

CPHI

中国医药控股
AMEX

实时行情|Nasdaq Last Sale

0.4050
-0.0052
-1.27%
盘后: 0.4050 0 0.00% 17:38 04/09 EDT
开盘
0.4000
昨收
0.4102
最高
0.4290
最低
0.3900
成交量
65.96万
成交额
--
52周最高
1.400
52周最低
0.2121
市值
1,765.02万
市盈率(TTM)
-0.8527
分时
5日
1月
3月
1年
5年

CPHI 新闻

更多
  • Edited Transcript of CPHI earnings conference call or presentation 31-Mar-20 12:30pm GMT
  • Thomson Reuters StreetEvents · 5天前
  • China Pharma Holdings Inc. (CPHI) CEO Zhilin Li on Q4 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript · 03/31 13:36
  • The Daily Biotech Pulse: Amarin Faces Legal Setback, Milestone Payment Kicks In For CytomX, Savara, Reata Disclose COVID-19 Disruptions
  • Benzinga · 03/31 12:26
  • China Pharma Holdings, Inc. Reports Fiscal Year 2019 Financial Results
  • PR Newswire · 03/31 11:30

所属板块

生物技术和医学研究
+1.63%
制药与医学研究
+0.82%

热门股票

代码
价格
涨跌幅

CPHI 简况

China Pharma Holdings, Inc. is a holding company. The Company conducts its production, marketing, finance, development and administrative activities through its subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson) in the People's Republic of China (PRC). It is engaged in the development, manufacture and marketing of pharmaceutical products for human use in connection with various diseases and medical conditions in the PRC. It manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, oral solutions and granules. Its pharmaceutical products are sold on a prescription basis and are approved by the China Food and Drug Administration (the CFDA). The Company manufactured over 20 pharmaceutical products for various diseases and medical indications. It offers products for Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases and Others.
展开

微牛提供China Pharma Holdings, Inc.(AMEX-CPHI)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的CPHI股票新闻,以帮助您做出投资决策。